295 related articles for article (PubMed ID: 29866771)
21. IκB kinase-β inhibitor IMD-0354 beneficially suppresses retinal vascular permeability in streptozotocin-induced diabetic mice.
Lennikov A; Hiraoka M; Abe A; Ohno S; Fujikawa T; Itai A; Ohguro H
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6365-73. PubMed ID: 25205865
[TBL] [Abstract][Full Text] [Related]
22. Neurovascular regulation in diabetic retinopathy and emerging therapies.
Ji L; Tian H; Webster KA; Li W
Cell Mol Life Sci; 2021 Aug; 78(16):5977-5985. PubMed ID: 34230991
[TBL] [Abstract][Full Text] [Related]
23. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.
Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607
[TBL] [Abstract][Full Text] [Related]
24. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
25. Deletion of miR-150 Exacerbates Retinal Vascular Overgrowth in High-Fat-Diet Induced Diabetic Mice.
Shi L; Kim AJ; Chang RC; Chang JY; Ying W; Ko ML; Zhou B; Ko GY
PLoS One; 2016; 11(6):e0157543. PubMed ID: 27304911
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of Connexin 43 promotes vascular cell loss and excess permeability associated with the development of vascular lesions in the diabetic retina.
Tien T; Muto T; Barrette K; Challyandra L; Roy S
Mol Vis; 2014; 20():732-41. PubMed ID: 24940027
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Jun HO; Yu YS; Kim KW
Am J Pathol; 2010 Mar; 176(3):1517-24. PubMed ID: 20110406
[TBL] [Abstract][Full Text] [Related]
28. Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy.
Zhang J; Gerhardinger C; Lorenzi M
Diabetes; 2002 Dec; 51(12):3499-504. PubMed ID: 12453906
[TBL] [Abstract][Full Text] [Related]
29. Vascular localization of heparan sulfate proteoglycans in retinas of patients with diabetes mellitus and in VEGF-induced retinopathy using domain-specific antibodies.
Witmer AN; van den Born J; Vrensen GF; Schlingemann RO
Curr Eye Res; 2001 Mar; 22(3):190-7. PubMed ID: 11462155
[TBL] [Abstract][Full Text] [Related]
30. A Systematic Investigation on Complement Pathway Activation in Diabetic Retinopathy.
Shahulhameed S; Vishwakarma S; Chhablani J; Tyagi M; Pappuru RR; Jakati S; Chakrabarti S; Kaur I
Front Immunol; 2020; 11():154. PubMed ID: 32117292
[TBL] [Abstract][Full Text] [Related]
31. Streptozotocin-induced diabetes--a rat model to study involvement of retinal cell types in the onset of diabetic retinopathy.
Rungger-Brändle E; Dosso AA
Adv Exp Med Biol; 2003; 533():197-203. PubMed ID: 15180265
[No Abstract] [Full Text] [Related]
32. Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage.
Kowluru RA; Mohammad G; dos Santos JM; Zhong Q
Diabetes; 2011 Nov; 60(11):3023-33. PubMed ID: 21933988
[TBL] [Abstract][Full Text] [Related]
33. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes.
Feit-Leichman RA; Kinouchi R; Takeda M; Fan Z; Mohr S; Kern TS; Chen DF
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4281-7. PubMed ID: 16249509
[TBL] [Abstract][Full Text] [Related]
34. Multifractal and lacunarity analyses of microvascular morphology in eyes with diabetic retinopathy: A projection artifact resolved optical coherence tomography angiography study.
Zhu T; Ma J; Li J; Dai X; Ye P; Su Z; Kong D; Ye J
Microcirculation; 2019 Apr; 26(3):e12519. PubMed ID: 30480851
[TBL] [Abstract][Full Text] [Related]
35. Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats.
Si YF; Wang J; Guan J; Zhou L; Sheng Y; Zhao J
Br J Pharmacol; 2013 Jun; 169(3):619-31. PubMed ID: 23488985
[TBL] [Abstract][Full Text] [Related]
36. Microvascular complications and diabetic retinopathy: recent advances and future implications.
Barot M; Gokulgandhi MR; Patel S; Mitra AK
Future Med Chem; 2013 Mar; 5(3):301-14. PubMed ID: 23464520
[TBL] [Abstract][Full Text] [Related]
37. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus.
Sohn EH; van Dijk HW; Jiao C; Kok PH; Jeong W; Demirkaya N; Garmager A; Wit F; Kucukevcilioglu M; van Velthoven ME; DeVries JH; Mullins RF; Kuehn MH; Schlingemann RO; Sonka M; Verbraak FD; Abràmoff MD
Proc Natl Acad Sci U S A; 2016 May; 113(19):E2655-64. PubMed ID: 27114552
[TBL] [Abstract][Full Text] [Related]
38. Nucleoside diphosphate kinase B deficiency causes a diabetes-like vascular pathology via up-regulation of endothelial angiopoietin-2 in the retina.
Qiu Y; Zhao D; Butenschön VM; Bauer AT; Schneider SW; Skolnik EY; Hammes HP; Wieland T; Feng Y
Acta Diabetol; 2016 Feb; 53(1):81-9. PubMed ID: 25900369
[TBL] [Abstract][Full Text] [Related]
39. Presence of retinal pericyte-reactive autoantibodies in diabetic retinopathy patients.
Zhang L; Li Y; Payne J; Srivastava S; Fan X; Fung J; Li X; Kern TS; Lin F
Sci Rep; 2016 Feb; 6():20341. PubMed ID: 26839120
[TBL] [Abstract][Full Text] [Related]
40. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
